Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Ovarian Neoplasms 23Breast Neoplasms 11Fallopian Tube Neoplasms 10Multiple Myeloma 7Carcinoma, Ovarian Epithelial 6Neoplasms 5Neoplasms, Plasma Cell 3Lymphoma 3Recurrence 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Lymphoma, Non-Hodgkin 2Carcinoma 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Patient Participation 1Ovarian Diseases 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Mesothelioma, Malignant 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Primary Effusion 1Liver Neoplasms 1

Interventions

Pemetrexed 9Cisplatin 9pembrolizumab 5defactinib 3Cyclophosphamide 3sodium thiosulfate 2Radiotherapy, Intensity-Modulated 2Platinum 2Immunoenzyme Techniques 2Doxorubicin 21,2-diaminocyclohexaneplatinum II citrate 2vatalanib 1spartalizumab 1osimertinib 1nintedanib 1liposomal doxorubicin 1cabozantinib 1antineoplaston AS 2-1 1antineoplaston A10 1amatuximab 1alvocidib 1aldesleukin 1X-Rays 1VS-5584 1Trabectedin 1Tetrahydrouridine 1Specimen Handling 1Ramucirumab 1Radiotherapy 1Radiation Dose Hypofractionation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Mesothelioma, Malignant × liposomal doxorubicin × Clear all
NCT00859495 2020-08-25

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

Columbia University

Phase 2 Terminated
9 enrolled 4 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡